April 21, 2020 Clinical Research/Diagn. Product Launch

Bio-Rad Begins Shipping SARS-COV-2 (COVID-19) Antibody Test That Offers More Than 99 Percent Specificity and 98 Percent Sensitivity

Date: 04/21/2020 HERCULES, Calif. –Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the commercial launch of its SARS-CoV-2 Total Ab test, a blood-based immunoassay kit to help determine if an individual has developed antibodies to SARS-CoV-2, the virus associated with COVID-19 disease. Bio-Rad has... Read more

April 21, 2020 Chromatography Clinical Research/Diagn.

AMETEK MOCON Supports Sterilization and Medical Gas Industry During COVID-19 Pandemic

Tuesday, April 21, 2020 Minneapolis, MN, (April 21, 2020) – AMETEK MOCON’s Baseline product group, a leading provider of industrial gas chromatographs and gas sensors, is prioritizing support for specific industries to ensure healthcare supplies continue to be delivered during the COVID-19 pandemic. The company will focus on medical personal protective equipment (PPE) suppliers and sterilizers... Read more

April 21, 2020 Clinical Research/Diagn. Informatics & Software

PrecisionLife offers analytics and resource support to COVID-19 coronavirus research community

Oxford, UK (21 April 2020) – PrecisionLife has confirmed it is extending its relationships with some of the largest COVID-19 collaborative research projects and is now offering free use of its unique analytics platform and support from its data and biomedical science teams to the on-going collaborative efforts of the medical research community in the fight... Read more

April 17, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

Promega successfully completes first fully remote quality surveillance assessment amid COVID-19 restrictions

Biotech manufacturer recommended for continued certification to ISO 9001:2015 and ISO 13485:2016 Madison, WI USA. (April 17, 2020) Promega Corporation announced today it successfully completed its first ever fully remote quality surveillance assessment and is recommended for continued certification to ISO 9001:2015 and ISO 13485:2016. Due to COVID-19 restrictions, the British Standards Institution (BSI) completed its six-day... Read more

April 16, 2020 Clinical Research/Diagn.

Promega to manufacture test kits for Co-Diagnostics’ new coronavirus test

Logix Smart™ COVID-19 Test is authorized for emergency use by the FDA, and CE marked to be sold in Europe Madison, WI USA. (April 16, 2020) Promega Corporation has been contracted by Utah-based Co-Diagnostics, Inc. to support Co-Diagnostics’ efforts to manufacture test kits of its new Logix Smart™ COVID-19 Test. Promega originally provided the custom master mix used... Read more

April 16, 2020 Clinical Research/Diagn. Informatics & Software Lab Top-10

Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announces the Illumina SARS-CoV-2 Data Toolkit, a new suite of data analysis tools and workflow functionality for researchers working with the virus using next-generation sequencing (NGS). The toolkit makes it easier for researchers to detect and identify the SARS-CoV-2 viral sequence in their samples and contribute their findings to... Read more

April 15, 2020 Clinical Research/Diagn. Product Launch

QIAGEN launches therascreen BRAF test as companion diagnostic to a BRAFTOVI® (encorafenib) based regimen in metastatic colorectal cancer

Germantown, Maryland, and Hilden, Germany, April 15 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced launch of its novel therascreen® BRAF V600E RGQ PCR Kit (therascreen BRAF V600E Kit) following U.S. Food and Drug Administration (FDA) approval as a companion diagnostic to the BRAF inhibitor, BRAFTOVI® (encorafenib), which the FDA has... Read more

April 13, 2020 Clinical Research/Diagn. Life Science Tools

BD Announces Second FDA Emergency Use Authorization, CE Mark for New COVID-19 Molecular Diagnostic for Global Use

New Test Uses BD MAX™ System to Augment Supply from Existing Collaborations; Test Results in Under Three HoursApr 13, 2020 FRANKLIN LAKES, N.J., April 13, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA)... Read more

April 13, 2020 Clinical Research/Diagn. Product Launch

Release of the “2019 Novel Coronavirus Detection Kit”Reduces labor and halves detection time

Shimadzu Corporation is announcing the release of its “2019 Novel Coronavirus Detection Kit”, with sales beginning on 20th April. For the time being the kits will only be available in Japan, but preparations are underway to export these kits overseas from May onwards. Current PCR methods for the detection of the novel coronavirus (SARS-CoV-2) require... Read more

April 11, 2020 Clinical Research/Diagn. M&A, Partnerships

Bruker partners with ANPC to support major new frontline response to combat the COVID-19 threat

Bruker is proud to partner with Australian National Phenome Centre (ANPC) at Murdoch University to support the work of their researchers into the COVID-19 pandemic threat. The ANPC team, led by world-renowned phenomics pioneer and academician Professor Jeremy Nicholson, and working with the South Metropolitan Health Service COVID-19 Response Team and the broader Western Australian... Read more